InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
-1.9%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Omstead Daniel R, Président. Director active across 2 companies, notably Tekla Life Sciences Investors. In total, 5 reports have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €661k. History available since 11 August 2021. The latest transaction was filed on 25 September 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Omstead Daniel R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
9,500 shares@ US$15.633249.8% of flowShares of Beneficial InterestSEC:0001104659-23-103574:0
Canonical exit: 24 Dec 2023 (T+90)
10,096 shares@ US$12.392623.8% of flowShares of Beneficial InterestSEC:0001104659-23-103576:0
Canonical exit: 24 Dec 2023 (T+90)
9,500 shares@ US$15.876750.2% of flowShares of Beneficial InterestSEC:0001104659-23-102458:0
Canonical exit: 19 Dec 2023 (T+90)
12,000 shares@ US$12.683828.8% of flowShares of Beneficial InterestSEC:0001104659-23-102460:0
Canonical exit: 19 Dec 2023 (T+90)
6,403 shares@ US$21.6331.1% of flowShares of Beneficial InterestSEC:0001104659-21-103959:0
Canonical exit: 9 Nov 2021 (T+90)
5 of 5 declarations
About Omstead Daniel R
Daniel R. Omstead is the President of Tekla Life Sciences Investors. He is responsible for managing and directing investments in the life sciences sector. His investment expertise is essential for maximizing the performance of Tekla's portfolio.
